This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Boehringer Ingelheim International Gmbh, Levo Therapeutics, Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,561 
1 out of 5 Years Active: 2021-2023
Title: Derrick Spencer Katayama - Innovator in Therapeutic Solutions
Introduction
Derrick Spencer Katayama is an accomplished inventor residing in Timnath, CO, USA. He has made notable contributions to the field of therapeutic innovations, specifically through his work in antibody formulations and treatments for neurodevelopmental disorders. With a remarkable portfolio of two patents, he demonstrates a commitment to enhancing healthcare solutions.
Latest Patents
1. **Anti-IL-36R Antibody Formulations**
This patent focuses on anti-interleukin-36 receptor (anti-IL-36R1) antibody formulations developed for administration to subjects. The invention presents potential therapeutic applications in treating conditions associated with the IL-36 receptor.
2. **Methods of Treating Prader-Willi Syndrome with Carbetocin**
Derrick's second patent describes stable aqueous compositions that comprise relatively high concentrations of carbetocin along with a solubilizer and/or surface-active agent. These compositions have shown effectiveness in treating Prader-Willi Syndrome, a neurodevelopmental disorder, while also exhibiting improved stability at room temperature and under stress conditions.
Career Highlights
Derrick Spencer Katayama has worked with prestigious companies such as Boehringer Ingelheim International GmbH and Levo Therapeutics, Inc. His roles in these organizations have contributed significantly to his expertise in developing innovative therapeutic solutions.
Collaborations
During his career, Derrick has collaborated with several talented individuals, including Sandra Nicole Denkinger and Anna Maria Steiner. These partnerships have helped drive his research forward and have been instrumental in the successful development of his patented inventions.
Conclusion
Derrick Spencer Katayama stands out as an innovative force in the field of therapeutic advancements. His patents on antibody formulations and treatments for disorders like Prader-Willi Syndrome reflect his dedication to enhancing healthcare solutions. As he continues to innovate, Derrick's contributions are sure to impact the medical field positively for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile